General MedicationsORALGeneric
SODIUM IODIDE I 131
SODIUM IODIDE I-131
Standard Dose
250-1000mCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 213615 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 250-1000mCi Sponsor CARDINAL HLTH 414 Submission history Latest submission status date: 2025-06-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 213615 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 250-1000mCi Sponsor CARDINAL HLTH 414 Submission history Latest submission status date: 2025-06-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.